Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity

Glycoconjugate Journal

Volumn 17, Issue 7-9, 2000, Pages 501-530

  Morgan, Walter T J ^a   Watkins, Winifred M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

A,B,H,Lea and Leb antigens; ABO and Lewis genetic loci: A,B,H, and Le gene specified glycosyltransferases; ABO blood groups; Blood group active ovarian cyst glycoproteins; Lewis blood groups

Indexed keywords

BLOOD GROUP ANTIGEN; GLYCOSIDASE; N ACETYLGALACTOSAMINYLTRANSFERASE;

ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; CHEMICAL STRUCTURE; ENZYME DEGRADATION; GENETIC MARKER; GENOTYPE; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS;

ABO BLOOD-GROUP SYSTEM; ALLELES; ANIMALS; AUTOBIOGRAPHY; CARBOHYDRATE SEQUENCE; ENGLAND; FEMALE; GLYCOSYLTRANSFERASES; HISTORY, 20TH CENTURY; HUMANS; ISOANTIBODIES; LEWIS BLOOD-GROUP SYSTEM; MOLECULAR SEQUENCE DATA; OVARIAN CYSTS;

EID: 0034440599     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011014307683     Document Type: Review

References (238)

1. 1 Landsteiner K, Zur kenntnis der antifermentativen, lytischen und agglutinierenden Wirkungen des blut serums und der lymphe, Zbl Bakt 27, 357-62 (1900).
2. 2 Landsteiner K, Uber agglutinationserscheinungen normalen menschlichen blutes, Wien Klin Wschr 14, 1132-4 (1901).
3. 3 Decastello A, Sturli A, Uber die isoagglutinine im Serumgesunder und kranker, Menschen Med Wschr 49, 1090-5 (1902).
4. 4 Epstein AA, Ottenberg R, Simple method of performing serum reactions, Proc New York Path Soc 8, 117-23 (1908).
5. 5 Bernstein F, Ergebnisse einer biostatischen zusamenfassenden Betrachtung, Klin Wschr 3, 1495-7 (1924).
6. 6 Thomsen O, Friedenreich V, Worsaae E, Uber die moglichkeit der existenz sweier neuer blutgruppen: auch ein Beitrag zur beleuchtung sogennanter untergruppen, Acta Path Microbiol Scand 7, 157-90 (1930).
7. 7 Yamamoto F, Clausen H, White I, Marken J, Hakomori S, Molecular genetic basis of the histo-blood group ABO system, Nature 345, 229-33 (1900).
8. 8 Ferguson-Smith MA, Aitkin DA, Turleau C, Grouchy J, Localisation of the human ABO:Np-1:AK-1 linkage group by regional assignment of AK-1 to 9q34, Hum Genet 34, 35-43 (1976).
9. 9 Yamakami K, The individuality of semen, with reference to its property of inhibiting specifically isoaagglutination, J Immunol 12, 185-9 (1926).
10. 10 Lehrs H, Uber gruppenspezifischen eigenschaften des menslichen Speichels, Z Immunforsch 66, 175-92 (1930).
11. 11 Putkonen T, Uber gruppenspezifischen eigenschaften verschiedener korper flussigkeiten, Acta Soc Med Fenn "Duodecim" A 14, (part 2) (1930).
12. 12 Schiff F, Sasaki H, Der auschiedunstypus, ein auf serologischem wege nachweisbares mendelnes merkal, Klin Woch 11, 1426-9 (1932).
13. 13 Schiff F, Adelsberger L, Z Immunforsch 40, 335 (1924) (cited in Wiener AS, Blood Groups and Transfusion, Thomas, Baltimore, 1943).
14. 14 Landsteiner K, van der Scheer, J Exp Med 42, 123 (1925) (cited in Wiener AS, Blood Groups and Transfusion, Thomas, Baltimore, 1943).
15. 15 Schiff F, Zbt Bakt 1 Abt Ref. 98, 94 (1930) (cited in Wiener AS, Blood Groups and Transfusion, Thomas, Baltimore, 1943).
16. 16 Landsteiner K, Harte RA, J Exp Med 71, 551 (1940) (cited in Wiener AS, Blood Groups and Transfusion, Thomas, Baltimore, 1943).
17. 17 Morgan WTJ, King HK, Studies in Immunochemistry 7. The isolation from hog gastric mucin of the polysaccharide-amino acid complex possessing blood group A specificity, Biochem J 37, 640-51 (1943).
18. 18 Yosida G, Uber die gruppenspezifischen unterschiede der transudate, Z Ges Exptl Med 63, 331-9 (1928).
19. 19 Morgan WTJ, Some observations on the carbohydrate-containing components of ovarian cyst mucin, Ann New York Acad Sci 106, 177-190 (1963).
20. 20 Morgan WTJ, van Heyningen R, The occurrence of A B and O blood group substances in pseudomucinous ovarian cyst fluids, Brit J Exp Path 25, 5-15 (1944).
21. 21 Partridge SM, Morgan WTJ, Artificial antigens with agar, gum acacia and cherry gum specificity, Brit J Exp Pathol 23, 84-94 (1942).
22. 22 Morgan WTJ, An artificial antigen with blood group A specificity, Brit J Exp Pathol 24, 41-9 (1943).
23. 23 Morgan WTJ, Watkins WM, A blood group A antigen prepared from an A-hapten of human origin, Brit J Exp Pathol 25, 221-8 (1944).
24. 24 Morgan WTJ, Watkins WM, The examination of rabbit anti-A immune sera produced by means of an artificial A antigen, Brit J Exp Pathol 26, 247-54 (1945).
25. 25 Rainsford SG, Morgan WTJ, Determination of blood groups: Use of rabbit immune serum, Lancet 154-6 ( 1946).
26. 26 Witebsky E, Klendshoj NC, The isolation of an O specific substance from gastric juice of secretors and carbohydrate-like substances from gastric juice of non-secretors, J Exp Med 73, 655-67 (1941).
27. 27 Morgan WTJ, Watkins WM, The detection of a product of the blood group O gene and the relationship of the so-called O-substance to the agglutinogens A and B, Brit J Exp Pathol 29, 159-73 (1948).
28. 28 Hirszfeld L, Amzel R, Sur les pleiades "isozeriques" du sang: Contribution a l'études des sous-groupes sanguins, Ann Inst Pasteur 65, 251-86 (1940).
29. 29 Bhende YM, Deshpande CK, Bhatia HM, Sanger R, Race RR, Morgan WTJ, Watkins WM, A "new" blood group character related to the ABO system, Lancet 1, 903-4 (1952).
30. 30 Watkins WM, Morgan WTJ, Some observations on the O and H characters of human blood and secretions, Vox Sang 5 (old series), 1-14 (1955).
31. 31 Mourant AE, A new human blood group antigen of frequent occurrence, Nature 158, 237 (1946).
32. 32 Andresen PH, The blood group system L. A new blood group L2. A case of epistasy within the blood groups, Acta Path Microbiol Scand 25, 728-31 (1948).
33. 33 Grubb R, Correlation between Lewis blood group and secretor character in man, Nature 162, 933 (1948).
34. 34 Brendemoen OJ, Studies of agglutination and inhibition in two Lewis antibodies, J Lab Clin Med 36, 335-41 (1949).
35. 35 Grubb R, Morgan WTJ, The "Lewis" blood group characters of erythrocytes and body fluids, Brit J Exp Pathol 30, 198-208 (1948).
36. 36 Ceppellini R, On the genetics of secretor and Lewis characters: A family study. In Proc Vth Congr Int Soc Blood Transf, Paris, 1954, p. 207 (1955).
37. 37 Morgan WTJ, Blood group specific mucopolysaccharides. In Methods in Carbohydrate chemistry, 5, 95-8, (Academic Press, New York, 1965).
38. 38 Aminoff D, Morgan WTJ, Watkins WM, Studies in Immunochemistry 8. The isolation and properties of the human blood group A substance, Biochem J 46, 426-38. Addendum Kekwick RA, Physicochemical examination of blood group A substance, 46, 438-9 (1950).
39. 38 Aminoff D, Morgan WTJ, Watkins WM, Studies in Immunochemistry 8. The isolation and properties of the human blood group A substance, Biochem J 46, 426-38. Addendum Kekwick RA, Physicochemical examination of blood group A substance, 46, 438-9 (1950).
40. 39 Gibbons RA, Morgan WTJ, Studies in Immunochemistry 14. The isolation and properties of substances of human origin possessing blood group B activity, Biochem J 57, 283-95 (1954).
41. a) substance, Biochem J 52, 259-60 (1952).
42. a) substance, Biochem J 52, 259-60 (1952).
43. a) human blood group substance, Biochem J 50, 460-70. Addendum Kekwick RA, Physicochemical examination of blood group-substance, Biochem J 50, 471-2 (1952).
44. a) human blood group substance, Biochem J 50, 460-70. Addendum Kekwick RA, Physicochemical examination of blood group-substance, Biochem J 50, 471-2 (1952).
45. 42 Morgan WTJ, The Croonian Lecture: A contribution to human biochemical genetics: the chemical basis of blood group specificity, Proc Roy Soc Series B 151, 308-47 (1960).
46. 43 Morgan WTJ, Watkins WM, The product of the human blood group A and B genes in individuals belonging to group AB, Nature 177, 521-2 (1956).
47. 44 Watkins WM, Some genetical aspects of the biosynthesis of human blood group substances, In Ciba Foundation Symposium on Biochemistry of Human Genetics, edited by Wolstenholme GWG and O'Connor CM, (Little Brown and Co, Boston), pp 217-41.
48. 45 Bray HG, Stacey M, Biochem J 40, 124 (1946).
49. 46 Aminoff D, Morgan WTJ, Hexosamine components of the human blood group substances, Nature 162, 579-580 (1948).
50. 47 Watkins WM, Morgan WTJ, Possible genetical pathways for the biosynthesis of blood-group mucopolysaccharides, Vox Sang 4, 97-119 (1959).
51. b specificity, J Immunol 102, 821-5 (1969).
52. 49 Landsteiner K, van der Scheer J, On the specificity of serological reactions with simple chemical compounds (inhibition reactions), J Exp Med 54, 295-305 (1931).
53. 50 Watkins WM, Morgan WTJ, Neutralisation of the anti-Hagglutinin in eel serum by simple sugars, Nature 169, 825-6 (1952).
54. 51 Renkonen KO, Studies on haemagglutinins present in seeds of some representatives of the family Leguminosae, Ann Med Exp Bio Fenn 26, 66-72 (1948).
55. 52 Boyd WC, Reguera RM, Haemagglutinating substances for human cells in various plants, J Immunol 62, 333-9 (1949).
56. 53 Morgan WTJ, Watkins WM, The inhibition of the haemagglutinins in plant seeds by human blood group substances and simple sugars, Brit J Exp Pathol 34, 94-103 (1953).
57. 54 Hindsgual O, Khare DP, Bach M, Lemieux RU, Molecular recognition III. The binding of the H-type 2 human blood group determinant by the lectin I of Ulex europaeus, Can J Chem 63, 2653-8 (1985).
58. 55 Kabat EA, Leskowitz, Immunochemical studies on blood groups XVII. Structural units involved in blood group A specificity, J Am Chem Soc 77, 5154-69 (1955).
59. 56 Watkins WM, Morgan WTJ, Inhibition by simple sugars of enzymes which decompose blood-group substances, Nature 175, 676-7 (1955).
60. 57 Kabat EA, Blood Group Substances: Their chemistry and Immunochemistry, (Academic Press, New York, 1956).
61. 58 Watkins WM, Blood-group specific substances, In Glycoproteins: their composition, structure and function, edited by Gottskchalk A (Elsevier, Amsterdam, 1966), pp. 462-515.
62. 59 Kuhn R, Les oligosaccharides du lait, Bull Soc Chim Biol 40, 297-314 (1958).
63. 60 Watkins WM, Morgan WTJ, Specific inhibition studies relating to the Lewis blood group system, Nature 180, 1038-40 (1957).
64. 61 Watkins WM, Changes in blood group specificity induced by enzymes. In Biochimie des Glucides, Structure-spécificité, Editions du Centre National de la Recherche Scientifique, Paris, pp. 271-7 (1961).
65. 62 Watkins WM, Changes in the specificity of blood group mucopolysaccharides induced by enzymes from Trichomonas foetus, Immunology 5, 245-66 (1962).
66. 63 Iseki S, Masaki S, Transformation of blood group substances by bacterial enzyme, Proc Japan Acad Sci 29, 460-5 (1953).
67. 64 Allen PZ, Kabat EA, Immunochemical studies on blood groups XXIII. Studies on the cross reactivity of untreated and partially hydrolysed blood group A, B and O(H) substances with Type XIV anti-pneumococcal horse serum, J Immunol 82, 358-72 (1959).
68. 65 Watkins WM, Morgan WTJ, Role of O-β-D-galactopyranosyl(1-4)-N-acetyl-glucosamine as inhibitor of the precipitation of blood group substances by an anti-Type 14 pneumococcal polysaccharide, Nature 178, 1289-90 (1956).
69. 66 Lindberg B, Lonngren J, Powell DA, Structural studies on the specific Type-14 pneumococcus polysaccharide, Carbohydr Res 58, 177-86 (1977).
70. 67 Watkins WM, Blood-group substances, Science 152, 172-81 (1966).
71. 68 Watkins WM, The multiple specificities of blood group mucopolysaccharides. Proc 7th Int Congr Blood Transfus Rome 1958, edited by Hollander L, (Karger, Basel, 1959), pp. 692-6.
72. 69 Ceppellini R, Physiological genetics of human blood factors, In Ciba Foundation Symposium on Biochemistry of Human Genetics, edited by Wolstonholme GEW, O'Connor CM, (Little, Brown and Co. Boston, 1959) pp. 242-63.
73. 70 Haldane JBS, The biochemistry of the individual. In Perspectives in Biochemistry, edited by Needham J, Green DE, (Cambridge University Press, Cambridge, 1937) pp. 1-10.
74. 71 Watson JD, Crick FHC, Molecular structure of the nucleic acids: a structure of deoxynucleic acid, Nature 171, 964-7 (1953).
75. 72 Leloir LF, The fifth Feodor Lynen lecture "I hate to bore people with my recollections" In Biology and Chemistry of eucaryotic cell surfaces, Miami Winter Symposium, edited by Lee EYC, Smith EE, Vol. 7, (Academic Press, New York, 1974) pp. 1-20.
76. 73 Watkins WM, The possible enzymic basis of the biosynthesis of blood group substances In Proc 3rd Int Congr Hum Genet, Chicago 1966, edited by Crow JF, Neel JV, (John Hopkins Press, Baltimore, 1967) pp. 171-87.
77. 74 Côté RH, Morgan WTJ, Some nitrogen-containing disaccharides isolated from human blood group A substance, Nature 178, 1171-2 (1956).
78. 75 Whistler RL, Durso DF, J Amer Chem Soc 72, 677 (1950).
79. 76 Partridge SM, Biochem Soc Symposia 3, 52 (1949).
80. 77 Cheese IAFL, Morgan WTJ, Two serologically active trisaccharides isolated from human blood-group A substance, Nature 191, 149-50 (1961).
81. 78 Schiffman G, Kabat EA, Leskowitz S, Immunochemical studies on blood groups XXVI. The isolation of oligosaccharides from human ovarian cyst blood group A substance including two disaccharides and a trisaccharide involved in the specificity of the blood group A antigenic determinant, J Amer Chem Soc 84, 73-4 (1962).
82. 79 Painter TJ, Water-soluble polystyrene sulphonic acid as a catalyst in the controlled fragmentation of very labile polysaccharides, Chem Ind (London) 1214-5 (1960).
83. 80 Painter TJ, Morgan WTJ, Water-soluble polystryrene sulphonic acid as a selective catalyst in the acid hydrolysis of basic polysaccharides, Chem Ind (London) 437 (1961).
84. 81 Painter TJ, Watkins WM, Morgan WTJ, Isolation of a B specific disaccharide from human blood group B substance, Nature 193, 1042-4 (1962).
85. 82 Painter TJ, Watkins WM, Morgan WTJ, Isolation of two serologically active trisaccharides from human blood group B-substance, Nature 199, 282-3 (1963).
86. a substances; possible sequences in the carbohydrate chains, Nature 200, 532-4 (1963).
87. 84 Rege VP, Painter TJ, Watkins WM, Morgan WTJ, Isolation of serologically active fucose-containing oligosaccharides from H substance, Nature 203, 360-3 (1964).
88. a substance, Nature 204, 740-2 (1964).
89. 86 Painter TJ, Watkins WM, Morgan WTJ, Serologically active fucose-containing oligosaccharides from human blood group A and B substances, Nature 206, 594-7 (1965).
90. b specificity, Nature 215 1345-9 (1967).
91. 88 Watkins WM, Biosynthesis 5. Molecular basis of antigenic specificity in the ABO, H and Lewis systems. In Glycoproteins, edited by Montreuil J, Vliegenthart JFG, Schachter S, (Elsevier, Amsterdam, 1995) pp. 313-90.
92. 2 blood group specific glycoproteins, Eur J Biochem 120, 243-9 (1981).
93. 90 Lloyd KO, Kabat EA, Layug EJ, Gruezo F, Immunochemical studies on blood groups XXXIV. Structures of some oligosacharides produced by alkaline degradation of blood group A, B, and H substances, Biochemistry 5, 1489-501 (1966).
94. 91 Lloyd KO, Kabat EA, Rosenfield RE, Immunochemical studies on blood groups XXXV. The activity of fucose-containing oligosaccharides isolated from blood-group A, B and H substances by alkaline degradation, Biochemistry 5, 1502-7 (1966).
95. b substances, Biochemistry 7, 2976-99 (1968).
96. 93 Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman ED, Hakomori S, Characterisation of sialylosylated Lewis x as a new tumour associated antigen, Cancer Res 44, 5279-85 (1984).
97. 94 Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ, Stage-specific embryonic antigen involves α1,3-fucosyltated Type 2 blood group chain, Nature 292, 156-8 (1981).
98. x determinant on myeloid and tumour cells, Science 250, 1132-5 (1990).
99. a active glycoprotein, Biochem J 110, 789-91 (1968).
100. x, the spurned antigen of the Lewis blood group system, Vox Sang 26, 425-38 (1974).
101. b and precursor substances, J Exp Med 135, 1247-58 (1972).
102. 99 Kabat EA, Liao J, Lemieux RU, Immunochemical studies on blood groups LXVIII. The combining site of anti-I Ma (Group 1), Immunochemistry 15, 727-31 (1978).
103. b substances. In Blood and Tissue Antigens, edited by Aminoff D, (Academic Press, New York, 1970) pp. 187-98.
104. a active glycoproteins by base-borohydride degradation, Biochemistry 12, 1955-61 (1973).
105. a specific substances, Biochem J 88, 546-56 (1963).
106. 103 Donald ASR, The products of pronase digestion of purified blood group specific glycoproteins, Biochim Biophys Acta 317, 420-36 (1973).
107. 104 Donald ASR, Creeth JM, Morgan WTJ, Watkins WM, The peptide moiety of human blood group active glycoproteins associated with the ABO and Lewis groups, Biochem J 115, 125-7 (1969).
108. 105 Donald ASR, Partial deglycosylation of blood-group-specific glycoproteins, Biochem J 185, 327-37 (1980).
109. 106 Kabat EA, Bassat EW, Pryzwansky K, Lloyd KO, Kaplan ME, Layug EJ, Immunochemical studies on blood groups XXXIII. The effects of alkaline boro-hydride and of alkali on blood group A, B and H substances, Biochemistry 4, 1632-8 (1965).
110. 107 Hanisch F, Muller S, MUC1: the polymorphic appearance of human mucin, Glycobiology 10, 439-49 (2000).
111. 108 Yamakawa T, Iida T, Immunological study of the red blood cells 1. Globoside as an agglutinogen of the ABO system on erythrocytes, Jap J Exp Med 23, 327-31 (1953).
112. 109 Koscielak J, Chemistry and biosynthesis of erythrocyte membrane glycolipids with A, B, H and I blood group activities. In Human Blood Croups, edited by Mohn JF, Plunkett RW, Cunningham RK, Lambert RM, (Karger, Basel, 1977), pp. 143-169.
113. 2 erythrocytes and their changes associated with ontogeny and oncogeny. In Human Blood Groups, edited by Mohn JF, Plunkett RW, Cunningham RK, Lambert RM, (Karger, Basel, 1977), pp. 150-163.
114. 111 Watkins WM, Koscielak J, Morgan WTJ, The relationship between the specificity of the blood group A and B substances isolated from erythrocytes and from secretions, Proc 9th Int Soc Blood Transfus, Mexico, 1962, pp. 213-9 (1964).
115. 112 Clausen H, Hakomori S, ABH and related histo-blood group antigens: immunochemical differences in carrier isotypes and their distribution, Vox Sang 56, 1-20 (1989).
116. 113 Koscielak J, Miller-Podraza H, Krauze R, Piasek A, Isolation and characterisation of poly(glycosyl)ceramides (megaloglycolipids) with A, H and I blood group activities, Eur J Biochem 71, 9-18 (1976).
117. 114 Finne J, Krusius T, Rauvala H, Kekomaki R, Myllyla G, Alkali-stable blood group A and B active poly(glycosyl)peptides from the human erythrocyte membrane, FEBS Lett 89, 111-5 (1978).
118. 115 Karhi KK, Gahmberg CG, Identification of blood group A glycoproteins in the human erythrocyte membranes, Biochem Biophys Acta 622, 344-54 (1980).
119. 116 Marcus DM, Cass LE, Glycosphingolipids with Lewis blood group activity: uptake onto erythrocytes, Science 164, 553-5 (1969).
120. 117 Oriol R, Samuelson BE, Messeter L, Workshop 1, ABO antibodies - serological behaviour and immunochemical characterization, J Immunogenet 17, 279-99 (1990).
121. 118 Szulman AE, The histological distribution of the blood group substances in man as disclosed by immunofluorescence III. The A, B and H antigens in embryos and fetuses from 18 mm in length, J Exp Med 119, 503-16 (1964).
122. 119 Szulman AE, Marcus DM, The histologic distribution of the blood group substances in man as disclosed by immunofluorescence, Lab Invest 28, 265-74 (1973).
123. 120 Hakkinen I, A-like blood group antigen in gastric cancer cells of patients in blood groups O and B, J Nat Cancer Inst 44, 1183-93 (1970).
124. 121 Ichikawa D, Handa K, Withers DA, Hakomori S, Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic motility, Cancer Res 57, 3092-6 (1997).
125. 122 Lemieux RU, Human blood groups and carbohydrate chemistry, Chem Soc Rev 7, 423-52 (1978).
126. 123 Lemieux RU, How proteins recognise and bind oligosaccharides. In Carbohydrate antigens edited by Garregg PJ, Lindberg AA, ACS Symposium Series 519, (American Chemical Society, Washington, 1991), pp. 5-18.
127. 124 Watkins WM, Hassid WZ, The synthesis of lactose by paniculate enzyme preparations from guinea pig and bovine mammary glands, J Biol Chem 237, 1432-40 (1962).
128. 125 Ziderman D, Gompertz S, Smith ZG, Watkins WM, Glycosyltransferases in mammalian gastric mucosal linings, Biochem Biophys Res Commun 29, 56-61 (1967).
129. 126 Hearn VM, Smith ZG, Watkins WM, An α-N-acetyl-D-galactosaminyltransferase associated with the human blood group A character, Biochem J 109, 315-7 (1968).
130. 127 Race C, Ziderman D, Watkins WM, An α-D-galactosyltransferase associated with the blood group B character, Biochem J 107, 733-35 (1968).
131. 128 Race C, Watkins WM, Properties of an α-D-galactosyltransferase in human tissues from group B donors, Biochem J 114, 86 (1969).
132. 129 Race C, Watkins WM, The biosynthesis of a blood group B-active tetrasaccharide, FEBS Lett 10, 279-83 (1969).
133. 130 Ginsburg V, Formation of guanosine diphosphate-L-fucose from guanosine diphosphate-mannose, J Biol Chem 235, 2196-201 (1960).
134. 131 Babab H, Hassid WZ, Soluble uridine diphosphate D-galactose:D-glucose β-4-galactosyltransferase from human milk, J Biol Chem 241, 2672-8 (1966).
135. 132 Shen L, Grollman EF, Ginsburg V, An enzymic basis for secretor status and blood group specificity in humans, Proc Natl Acad Sci USA 59, 224-30 (1968).
136. 133 Grollman EF, Kobata A, Ginsburg V, An enzymatic basis for Lewis blood types in man, J Clin Invest 48, 1489-94 (1968).
137. 134 Kobata A, Grollman EF, Ginsburg V, An enzymic basis for blood Type A in humans, Arch Biochem Biophys 124, 609-12 (1968).
138. 135 Kobata A, Grollman EF, Ginsburg V, An enzymic basis for blood Type B in humans, Biochem Biophys Res Commun 32, 272-7 (1968).
139. b blood group characters and ABH secretor status, Biochem Biophys Res Commun 34, 835-42 (1969).
140. 137 Sawicka, Glycosyltransferases in human plasma, FEBS Lett 16: 346-8 (1971).
141. 138 Kim YS, Perdoma J, Bella A, Nordberg J, N-acetyl-D-galactosaminyl transferase in human serum and erythrocyte membranes, Proc Natl Acad Sci USA 68, 1753-6 (1971).
142. 139 Watkins WM, Biochemistry and genetics of the ABO, Lewis and P blood group systems, Adv Hum Genet 10, 1-136 (1980).
143. 140 Tuppy H, Schenkel-Brunner H, Enzymatic conversion of human blood group O erythrocytes into A erythrocytes and of A into AB cells, Nature 223, 1273 (1969).
144. 141 Schenkel-Brunner H, Chester MA, Watkins WM, α-L-fucosyl-transferases in human serum from donors of different ABO, secretor and Lewis blood group phenotypes, Eur J Biochem 17, 218-22 (1972).
145. h donors, FEBS Lett 27, 125-30 (1972).
146. 143 Chester MA, Yates AD, Watkins WM, Phenyl-β-galactoside as an acceptor substrate for the H-gene associated guanosine diphosphate L-fucose β-D-galactosyl α-2-fucosyltransferase, Eur J Biochem 69, 583-92 (1976).
147. 144 Mulet C, Cartron JP, Badet J, Salmon C, Activity of α-L-fucosyltransferase in human sera and red cell membranes, FEBS Lett 84, 74-8 (1977).
148. 1 determinant, Biochem Biophys Res Commun 61, 1289-96 (1974).
149. a antigen, Biochem Soc Trans 15, 606-8 (1987).
150. 2 genes, Proc Natl Acad Sci USA 70, 220-4 (1973).
151. 2 and B-gene associated glycosyltransferases in ovarian cyst fluids and serum, Biochem Biophys Res Commun 64, 89-96 (1975).
152. 149 Watkins WM, Greenwell P, Yates AD, Blood group A and B rransferase levels in serum and red cells of human chimeras, Blood Transfus Immunohematol 23, 531-44 (1980).
153. 150 Wrobel DM, McDonald I, Race C, Watkins WM, "True" genotype of chimeric twins revealed by blood group gene products in plasma, Vox Sang 27, 283-7 (1974).
154. 151 Watkins WM, Yates AD, Greenwell P, Bird GWG, Gibson M, Roy RCF, Wingham J, Loeb W, A human chimaera first suspected from analyses of the blood group gene specified glycosyltransferases, J Immunogenet 8, 113-28 (1981).
155. 152 Iselius L, Lambert B, Lindsten J, Tippett P, Gavin J, Daniels G, Yates A, Ritzen M, Sanstedt B, Unusual XX/XY chimerism, Ann Hum Genet, Lond 43, 89-96 (1979).
156. 153 Watkins WM, Greenwell P, Yates AD, Johnson PH, Regulation of expression of carbohydrate blood group antigens, Biochimie 70, 1597-1611 (1988).
157. 2B on the red cells of individuals with strong B gene-specified transferase, Transfusion 25, 30-3 (1985).
158. 2, Acta Genet Statist Med 6, 521-6 (1957).
159. 2 distinction, Proc Natl Acad Sci USA 82, 1199-1203 (1985).
160. 2 erythrocytes, Eur J Biochem 122, 511-4 (1982).
161. 158 Cook GA, Greenwell P, Watkins WM, A rabbit antibody to the blood-group-A-gene specified α-3-N-acetylgalactosaminyltransferase, Biochem Soc Trans 10, 446-7 (1982).
162. 159 Yoshida A, Yamaguchi YF, Dave V, Immunological homology of human blood group glycosyltransferases and genetic background of blood group (ABO) determination, Blood 54, 344-50 (1979).
163. 160 Greenwell P, Yates AD, Watkins WM, UDP-N-acetyl-D-galactosamine as a donor substrate for the glycosyltransferase encoded by the B gene at the human blood group ABO locus, Carbohydr Res 149, 149-70 (1986).
164. 161 Yates AD, Feeny J, Donald ASR, Watkins WM, Characterisation of a blood group A-active tetrasaccharide synthesised by a blood group B gene specified glycosyltransferase, Carbohydr Res 130, 251-60 (1984).
165. 162 Yates AD, Overlapping functions of the glycosyltransferases encoded by the blood group A and B genes: Biochemical basis and practical implications. In Progress in Immunohaematology, edited by Moore SB, (American Association of Blood Banks, Arlington VA, 1988), pp. 65-91.
166. 163 Yates AD, Watkins WM, The biosynthesis of blood group B determinants by the blood group A gene specified α-3-N-acetylgalactosaminyltransferase, Biochem Biophys Res Commun 109, 958-65 (1982).
167. 164 Badet J, Ropars C, Cartron JP, Salmon C, Groups of α-D-galactosyl transferase activity in sera of individuals with normal B phenotype, Biomedicine 21, 230-2 (1974).
168. 165 Yamamoto F, Hakomori S, Sugar nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions, J Biol Chem 265, 19257-62 (1990).
169. 166 Yamamoto F, McNeill PD, Amino acid residue at codon 268 determines both activity and nucleotide-sugar donor substrate specificity of human blood group A and B transferases, J Biol Chem 271, 10515-20 (1996).
170. 167 Brederode J van, Nigtevecht G van, Dominance relationships between two allelic genes containing glycosyltransferases with different substrate specificities in Melandrium, Genetics 77, 507-20 (1974).
171. 168 Greenwell P, Watkins WM, Demonstration of fucosyl-α1,2galactoside α1,3-N-acetyl-galactosaminyltransferase activity in the serum and tissues of blood group O individuals, Proc 9th Symp Glycoconjugates, Lille, France, Abstract E34, (1987).
172. 169 Harduin-Lepers A, Recchi M-A, Delannoy P, 1994, the year of sialyltransferases, Glycobiology 5, 741-58 (1995).
173. 170 Weston BW, Smith PL, Kelly RJ, Lowe JB, Molecular cloning of a fourth member of a human α(1-3)fucosyltransferase gene family, J Biol Chem 267, 24575-84 (1972).
174. 171 Levine P, Robinson E, Celano M, Briggs O, Falkenburg L, Gene interaction resulting in suppression of blood group substance B, Blood 10, 1100-8 (1955).
175. 172 Oriol R, Danilovs J, Hawkins BR, A new genetic model proposing that the Se gene is a structural gene closely linked to the H gens, Am J Hum Genet 33, 421-31 (1980).
176. 173 Race RR, Sanger R, Blood Groups in Man, 6th edition (Blackwell Scientific Publications, Oxford, 1975), pp. 24-7.
177. 174 Betteridge A, Watkins WM, Variant forms of α-2-fucosyltransferase in human submaxillary glands from blood group ABH "secretor" and "non-secretor" individuals, Glycoconjugate J 72, 61-78 (1985).
178. 175 Kumasaki T, Yoshida A, Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase, Proc Natl Acad Sci USA 81, 4193-7 (1984).
179. 176 Le Pendu J, Oriol R, Juszczak G, Liberge G, Rouger P, Salmon C, Cartron J-P, α-2-L-Fucosyltransferase activity in sera of individuals with H-deficient red cells and normal H antigen in secretions, Vox Sang 44, 360-5 (1983).
180. 177 Kyprianou P, Betteridge A, Donald ASR, Watkins WM, Purification of the blood group H gene associated α-2-fucosyltransferase from human plasma, Glycoconjugate J 7, 573-88 (1990).
181. 178 Larsen RD, Ernst LK, Nair RP, Lowe JB, Molecular cloning, sequence and expression of a human GDP-L-fucose: β-D-galactoside α-2-L-fucosyltransferase cDNA that can form the H blood group antigen, Proc Natl Acad Sci USA 87, 6674-8 (1990).
182. 179 Oriol R, Candelier J-J, Mollicone R, Moleular genetics of H, Vox Sang 78 (suppl 2), 105-8 (2000).
183. 180 Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D, Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus related DNA restriction fragments, J Biol Chem 270, 4632-9 (1995).
184. 181 Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB, Sequence and expression of a candidate for the human secretor blood group α1,2-fucosyltransferase gene, J Biol Chem 270, 4640-8 (1995).
185. 182 Koda Y, Soejima M, Kimura H, Structure and expression of the gene encoding secretor type 2-α-L-fucosyltransferase (FUT2), Eur J Biochem 246, 750-5 (1997).
186. 183 Ball SP, Tongue N, Gibaud A, Le Pendu J, Mollicone, Gerard G, Oriol R, The human chromosome 19 linkage group FUT1 (H), FUT2 (SE), LE, LU, PEPD, C3, APOC2, D19S7, D19S9, Ann Hum Genet 55, 225-33 (1991).
187. 184 Johnson PH, Yates AD, Watkins WM, Human salivary fucosyltransferase: Evidence for two distinct a-3-fucosyltransferase activities one of which is associated with the Lewis blood group gene, Biochem Biophys Res Commun 100, 1611-18 (1981).
188. 185 Prieels JP, Monnom D, Dolmans M, Beyer TA, Hill RL, Co-purification of the Lewis blood group N-acetylglucosaminide α1,4-fucosyltransferase and an N-acetylglucosaminide α 1,3-fucosyltransferase from human milk, J Biol Chem 256, 10456-63 (1981).
189. 186 Johnson PH, Watkins WM, Separation of an α1,3-fucosyltransferase from the blood group Le-gene specified α3/4-fucosyltransferase in human milk, Biochem Soc Trans 10, 445-6 (1982).
190. 187 Johnson PH, Donald ASR, Feeney J, Watkins WM, Reassessment of the specificity and general properties of the Lewis blood group gene associated α-3/4-fucosyltransferase purified from human milk, Glycoconjugate J 9, 251-64 (1992).
191. 188 Johnson PH, Donald ASR, Watkins WM, Purification and properties of the a3/4-fucosyltransferase released into the medium during growth of the A431 epidermoid carcinoma cell line, Glycoconjugate J 10, 152-64 (1993).
192. 189 Johnson PH, Watkins WM, Sialyl compounds as acceptor substrates for the human α3-and α3/4-fucosyltransferases, Biochem Soc Trans 13, 1119-20 (1985).
193. 190 Skacel PO, Watkins WM, Fucosyltransferase expression in human platelets and leucocytes, Glycoconjugate J 4, 267-72 (1987).
194. 191 Johnson PH, Watkins WM, Sialyl compounds as acceptor substrates for fucosyltransferases in normal and leukaemic human granulocytes, Biochem Soc Trans 15, 396 (1987).
195. 192 Clarke JL, Watkins WM, Independent regulation of Fuc-TIV and Fuc-TVII genes leading to modulation of cell surface expression in developing myeloid cells, Glycobiology 7, 835-46 (1997).
196. 193 Kukowska-Latallo JF, Larsten RD, Nair RP, Lowe JB, A cloned human cDNA determines expression of a mouse stage specific embryonic antigen and the Lewis blood group α(1,3/4)fucosyltransferase, Genes Dev 4, 1288-303 (1990).
197. 194 de Vries T, Smka CA, Palcic MP, Swiedler S, van den Eijnden DH, Macher BA, Acceptor specificity of different constructs of human recombinant α1,3/4-fucosyltransferases, J Biol Chem 270, 8712-22 (1995).
198. 195 Costa J, Grabenhorst E, Nimzt M, Conradt HS, Stable expression of the Golgi form and secretory variants of human fucosyltransferase III from BHK cells, J Biol Chem 272, 11613-21 (1997).
199. 196 Mollicone R, Cailleau A, Oriol R, Molecular genetics of H, Se, Lewis and other fucosyltransferases. TCB 4, 235-42 (1995).
200. 197 Nagai N, Dave V, Kaplan BE, Yoshida A, Human blood group glycosyltransferases I. Purification of N-acetylgalactosaminyltransferase, J Biol Chem 253, 377-9 (1978).
201. 198 Nagai N, Dave V, Muensch H, Yoshida A, Human blood group glycosyltransferases II. Purification of galactosyltransferase, J Biol Chem 253, 380-1 (1978).
202. 199 Carne LR, Watkins WM, Human blood group B gene specificied α-3-galactosyltransferase: purification of the enzyme in serum by biospecific adsorption onto blood group O erythrocytes membranes, Biochem Biophys Res Commun 77, 700-7 (1977).
203. 200 Whitehead JS, Bella A, Kim YS, An N-acetylgalactosaminyl transferase from human group A plasma. Purification and agarose binding properties, J Biol Chem 249, 3442-7 (1974).
204. 201 Greenwell P, Edwards YH, Williams J, Watkins WM, Approaches to cloning the genes at the human blood group ABO locus, Biochem Soc Trans 15, 601-3 (1987).
205. 202 Navaratnam N, Watkins WM, Purification of human A gene specified α-3-N-acetylgalactosaminyl transferase from human lung. In Proc 10th Int Symp Glycoconjugates Jerusalem, 1989, edited by Sharon N, Lis H, Duksin D, Kahane I, Abstract 154, pp. 225-6.
206. 203 Navaratnam N, Findlay JBC, Keen JN, Watkins WM, Purifcation, properties and partial amino acid sequence of the blood group A-gene associated α-3-N-acetylgalactosaminyl transferase from human gut mucosal tissue, Biochem J 271, 93-8 (1990).
207. 204 Clausen H, White T, Takio K, Titani K, Stroud M, Holmes E, Karkov J, Thim L, Hakomori S, Isolation to homogeneity and partial characterisation of a histo-blood group A transferase (UDP-GalNAc:Fuc α1-2Gal α1-3 N-acetylgalactosaminyltransferase) from human lung tissue, J Biol Chem 265, 1139-45 (1990).
208. 205 Yamamoto F, Marken J, Tsuji T, White T, Clausen H, Hakomori S, Cloning and characterisation of DNA complementary to human UDP-GalNAc:Fucal-2Gal 3-GalNac transferase (Histo-blood group A transferase) mRNA, J Biol Chem 265, 1146-51 (1990).
209. 206 Yamamoto F, McNeill PD, Hakomori S, Genomic organisation of human histo-blood group ABO genes, Glycobiology 5, 51-8 (1995).
210. 207 Bennett EP, Steffensen R, Clausen H, Weghuis DO, van Kessel AG, Genomic cloning of the human histo-blood group ABO locus, Biochem Biophys Res Commun 206, 308-25 (1995).
211. 208 Cartron JP, Properties of α-N-acetylgalactosaminyltransferases in sera of weak A erythrocyte phenotypes, Rev Fr Transfus Immunohaematol 19, 67-88 (1976).
212. 209 Johnson PH, Hopkinson DA, Detection of ABO blood group polymorphism by denaturing gel electrophoresis, Hum Mol Genet 1, 341-4 (1992).
213. 210 Yamamoto F, McNeill PD, Yamamoto M, Hakomori S, Bromilow IM, Duguid KM, Molecular genetic analysis of the ABO system: 4. Another type of O allele, Vox Sang 64, 175-8 (1993).
214. 2, Vox Sang 67, 210-15 (1994).
215. 1 gene at the blood group ABO locus, Vox Sang 70, 26-30 (1996).
216. el nucleotide insertion, Vox Sang 7, 113-7 (1996).
217. 214 Mourant AE, Kopec AC, Domaniewska-Sobczak K, The distribution of human blood groups and other polymorphisms, (2nd edition, Oxford University Press, London, 1976).
218. 2 allele, one of the A subtypes is characterised by a single base deletion in the coding sequence which results in an additional domain at the carboxy terminal, Biochem Biophys Res Commun 187, 366-74 (1992).
219. 216 Yamamoto F, Molecular genetics of ABO, Vox Sang 78 (Suppl 2), 91-103 (2000).
220. 217 Kominata Y, Tsuchiya T, Hata N, Takizawa H, Yamamoto F, Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/ NF-Y to mini-satellite sequence, J Biol Chem 272, 25890-8 (1997).
221. 218 Irshaid NM, Chester MA, Olsson ML, Allele related variation in minisatellite repeats involved in the transcription of the blood group ABO gene, Transfus Med 9, 219-26 (1999).
222. 219 Kominata Y, Hata N, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F, Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region, J Biol Chem 24, 37240-50 (1999).
223. 220 Iwamoto S, Withers DA, Handa K, Hakomori S, Deletion of A antigens in a human cancer cell line is associated with reduced promotor activity of CNF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promotor, Glycoconjugate J 16, 659-66 (1999).
224. 221 Hattori H, Uemura K-I, Taketomi T, Glycolipids of gastric cancer: The presence of blood group A-active glycolipids in cancer tissues from blood group O patients, Biochim Biophys Acta 666, 361-9 (1981).
225. 222 Clausen H, Bennett EP, Grunnet N, Molecular genetics of ABO histo-blood groups, TCB 2, 79-89 (1994).
226. x phenotype, Transfus Med 8, 231-8 (1998).
227. 224 Olsson ML, Guerreiro JF, Zago MA, Chester MA, Molecular analysis of the O alleles at the blood group ABO locus in populations of different ethnic origin reveals novel crossing over events and point mutations, Biochem Biophys Res Commun 234, 779-82 (1997).
228. 225 Susuki K, Iwata M, Tsuji H, Takagi T, Tamura A, IshimotoG, Ito S, Matsui K, Miyazaki T, A de novo recombination in the ABO blood group gene and evidence for the occurrence of recombination products, Hum Genet 99, 454-61 (1997).
229. 226 Seto NOL, Palcic MM, Compston H, Li D, Bundle DR, Narang SA, Sequential interchange of four amino acids from blood group B to blood group A glycosyltransferase boosts catalytic activity and progressively modifies substrate recognition in human recombinant enzymes, J Biol Chem 272, 14133-8 (1997).
230. 227 Seto NOL, Compston H, Evans SV, Bundle DR, Narang SA, Palcic MM, Donor substrate specificity of recombinant human blood group A, B and hybrid A-B glycosyltransferases expressed in Escherichia coli, Eur J Biochem 259, 770-5 (1999).
231. 228 Seto NOL, Compston H, Szpacenko A, Palcic MM, Enzymatic synthesis of blood group A and B trisaccharide analogues, Carbohydr Res 324, 161-9 (2000).
232. 229 Barbolla L, Mojena M, Bosca L, Presence of antibody to A-and B-transferases in minor incompatible bone marrow transplants, Brit J Haematol 70, 471-6 (1988).
233. 230 Kominata Y, Fujikura T, Shirnada I, Takisawa H, Hayashi K, Mori T, Monoclonal antibody to blood group glycosyltransferases produced by hybrids constructed with Epstein-Barr-Virus transformed B lymphocytes from a patient with an ABO incompatible bone marrow transplant and mouse myeloma cells, Vox Sang 59, 116-8 (1990).
234. 231 Greenwell P, Blood group antigens: molecules seeking a function?, Glycoconjugate J 14, 159-73 (1997).
235. 232 Shima M, Fujimura Y, Nishiyama T, Tsuijiuchi T, Narita N, Matsui T, Titani K, Katayama MF, Yoshioka A, ABO blood group genotype and plasma von Willebrands factor in normal individuals, Vox Sang 68, 236-40 (1995).
236. 233 Vlot AJ, Mauser-Bunschoten P, Zarkova AG, Haan E, Fruitwagen CLJJ, Sixma JJ, van den Berg HM, The half life of infused Factor VIII is shorter in haemophiliac patients with blood group O than in those with blood group A, Thromb Haemost 83, 65-9 (2000).
237. 234 Osborn MJ, Rosen SM, Rothfield L, Zeleznick LD, Horecker BL, Lipopolysaccharide of the gram-negative cell wall, Science 145, 783-9 (1964).
238. 235 Olsson ML, Molecular genetic studies of the blood group ABO locus in man, PhD Thesis, University of Lund (1997).